Qianshan Pharmaceutical Co. , Ltd. set up a joint venture in the United States to focus on the production of non-PVC film soft bag large infusion
Qianshan medicine machine (300216) Announcement, Qianshan pharmaceutical machinery company will set up a joint venture with Canadian ACIC company in the United States, with a registered capital of 25 million yuan and a 80% stake in the company.
According to the announcement, joint venture ACIC is a company that provides all-round services in medicine and fine chemicals, the joint venture company will first focus on the research and development, production and sales of non-PVC film soft bag large infusion production automatic line, plastic bottle injection production automatic line, etc. , and is committed to becoming a new product research and development base, international customization and assembly bases of products, market development and sales bases for high-end customers in Europe and America, and procurement and supply of raw materials and spare parts and after-sales service bases. It is estimated that the sales revenue will reach 30 million yuan in 2012, reaching 0. 2 billion yuan in five years, and the net profit will be 40 million yuan. The annual sales and net profit growth rate will both exceed 50%.
The Company 2011 Report display 2011 Business total income 2. 6. 4 billion yuan, a year-on-year increase of 24. 99%; Net profit 5155. 100 thousand yuan, a year-on-year increase of 13. 98%; Basic earnings per share 0. 86 yuan. The company intends to transfer 10 shares to all shareholders for every 10 shares and distribute a cash dividend of 3 yuan (Tax included). The company plans to achieve operating income this year. 0. 5 billion yuan, net profit 76 million yuan.
In addition, the company also announced the performance forecast for the first quarter of 2012. Affected by the macro environment, especially the implementation of the new GMP, the company announced some order delays and delayed delivery, which affected the first quarter performance. Is expected to first quarter net profit 720-10. 2 million yuan, with a range-30%-0%.
